ReP USP - Resultado da busca

Artigo de periodico
Immune responses and therapeutic antitumor effects of an experimental DNA vaccine encoding human Papillomavirus type 16 oncoproteins genetically fused to Herpesvirus glycoprotein D (2010)
Diniz, Mariana de Oliveira; Lasaro, Marcio O.; Ertl, Hildegund C.; Ferreira, Luís Carlos de Souza
Source: Clinical Vaccine Immunology. Unidade: ICB
Assunto: MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DINIZ, Mariana de Oliveira et al. Immune responses and therapeutic antitumor effects of an experimental DNA vaccine encoding human Papillomavirus type 16 oncoproteins genetically fused to Herpesvirus glycoprotein D. Clinical Vaccine Immunology, v. 17, n. 10, p. 1576-1583, 2010Tradução . . Disponível em: https://doi.org/10.1128/CVI.00264-10. Acesso em: 29 maio 2024.
APA
Diniz, M. de O., Lasaro, M. O., Ertl, H. C., & Ferreira, L. C. de S. (2010). Immune responses and therapeutic antitumor effects of an experimental DNA vaccine encoding human Papillomavirus type 16 oncoproteins genetically fused to Herpesvirus glycoprotein D. Clinical Vaccine Immunology, 17( 10), 1576-1583. doi:10.1128/CVI.00264-10
NLM
Diniz M de O, Lasaro MO, Ertl HC, Ferreira LC de S. Immune responses and therapeutic antitumor effects of an experimental DNA vaccine encoding human Papillomavirus type 16 oncoproteins genetically fused to Herpesvirus glycoprotein D [Internet]. Clinical Vaccine Immunology. 2010 ; 17( 10): 1576-1583.[citado 2024 maio 29 ] Available from: https://doi.org/10.1128/CVI.00264-10
Vancouver
Diniz M de O, Lasaro MO, Ertl HC, Ferreira LC de S. Immune responses and therapeutic antitumor effects of an experimental DNA vaccine encoding human Papillomavirus type 16 oncoproteins genetically fused to Herpesvirus glycoprotein D [Internet]. Clinical Vaccine Immunology. 2010 ; 17( 10): 1576-1583.[citado 2024 maio 29 ] Available from: https://doi.org/10.1128/CVI.00264-10
Artigo de periodico
A DNA vaccine encoding the enterohemorragic Escherichia coli shiga-like toxin 2 'A ind.2' and B subunits confers protective immunity to shiga toxin challenge in the murine model (2009)
Bentancor, Letícia V.; Bilen, Marcos; Brando, Romina J Fernández; Ramos, María Victoria; Ferreira, Luís Carlos de Souza ; Ghiringhelli, Pablo D; Palermo, Marina S
Source: Clinical Vaccine Immunology. Unidade: ICB
Assunto: MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BENTANCOR, Letícia V. et al. A DNA vaccine encoding the enterohemorragic Escherichia coli shiga-like toxin 2 'A ind.2' and B subunits confers protective immunity to shiga toxin challenge in the murine model. Clinical Vaccine Immunology, v. 16, n. 5, p. 712-718, 2009Tradução . . Acesso em: 29 maio 2024.
APA
Bentancor, L. V., Bilen, M., Brando, R. J. F., Ramos, M. V., Ferreira, L. C. de S., Ghiringhelli, P. D., & Palermo, M. S. (2009). A DNA vaccine encoding the enterohemorragic Escherichia coli shiga-like toxin 2 'A ind.2' and B subunits confers protective immunity to shiga toxin challenge in the murine model. Clinical Vaccine Immunology, 16( 5), 712-718.
NLM
Bentancor LV, Bilen M, Brando RJF, Ramos MV, Ferreira LC de S, Ghiringhelli PD, Palermo MS. A DNA vaccine encoding the enterohemorragic Escherichia coli shiga-like toxin 2 'A ind.2' and B subunits confers protective immunity to shiga toxin challenge in the murine model. Clinical Vaccine Immunology. 2009 ; 16( 5): 712-718.[citado 2024 maio 29 ]
Vancouver
Bentancor LV, Bilen M, Brando RJF, Ramos MV, Ferreira LC de S, Ghiringhelli PD, Palermo MS. A DNA vaccine encoding the enterohemorragic Escherichia coli shiga-like toxin 2 'A ind.2' and B subunits confers protective immunity to shiga toxin challenge in the murine model. Clinical Vaccine Immunology. 2009 ; 16( 5): 712-718.[citado 2024 maio 29 ]
Artigo de periodico
Antigenic polymorphism and naturally acquired antibodies to Plasmodium vivax merozoite surface protein 1 in Rural Amazonians (2007)
Bastos, Melissa S.; Silva-Nunes, Mônica da; Malafronte, Rosely dos Santos; Hoffmann, Erika Hellena E.; Wunderlich, Gerhard ; Moraes, Sandra do Lago; Ferreira, Marcelo Urbano
Source: Clinical Vaccine Immunology. Unidades: ICB, FM
Assunto: PARASITOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASTOS, Melissa S. et al. Antigenic polymorphism and naturally acquired antibodies to Plasmodium vivax merozoite surface protein 1 in Rural Amazonians. Clinical Vaccine Immunology, v. 14, n. 10, p. 1249-1259, 2007Tradução . . Acesso em: 29 maio 2024.
APA
Bastos, M. S., Silva-Nunes, M. da, Malafronte, R. dos S., Hoffmann, E. H. E., Wunderlich, G., Moraes, S. do L., & Ferreira, M. U. (2007). Antigenic polymorphism and naturally acquired antibodies to Plasmodium vivax merozoite surface protein 1 in Rural Amazonians. Clinical Vaccine Immunology, 14( 10), 1249-1259.
NLM
Bastos MS, Silva-Nunes M da, Malafronte R dos S, Hoffmann EHE, Wunderlich G, Moraes S do L, Ferreira MU. Antigenic polymorphism and naturally acquired antibodies to Plasmodium vivax merozoite surface protein 1 in Rural Amazonians. Clinical Vaccine Immunology. 2007 ; 14( 10): 1249-1259.[citado 2024 maio 29 ]
Vancouver
Bastos MS, Silva-Nunes M da, Malafronte R dos S, Hoffmann EHE, Wunderlich G, Moraes S do L, Ferreira MU. Antigenic polymorphism and naturally acquired antibodies to Plasmodium vivax merozoite surface protein 1 in Rural Amazonians. Clinical Vaccine Immunology. 2007 ; 14( 10): 1249-1259.[citado 2024 maio 29 ]

USP Schools

ReP

Filtros

Authors

Indexado em